Trane Technologies plc vs Vir Biotechnology Inc. Common Stock — how do they compare? Trane Technologies plc trades at $471.85 (market cap $105.17B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Trane Technologies plc is far larger — about 58.4× Vir Biotechnology Inc. Common Stock's market cap, and Trane Technologies plc pays a 0.88% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals.
| TT | VIR | |
|---|---|---|
Market Cap | $105.17B | $1.80B |
Volume | 1,040,183 | 1,782,836 |
Sector | Industrials | Health |
52-Week High | $503.46 | $11.78 |
52-Week Low | $376.43 | $5.12 |
Enterprise Value | $108.47B | $1.36B |
Dividend Yield | 0.88% | — |
Typical Hold Time | — | 0 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →